1
Feb 17, 2026
The Yield Paradox: Turning Strict Protocols into Recruitment Success: In clinical development, recruitment is often judged by volume. But the reality is a “Yield Paradox”: high applicant numbers frequently lead to low enrollment efficiency and site burnout.The Challenge: The “Eligibility Wall” In a recent early-stage breast cancer study, we saw this firsthand. While the trial […]
2
Apr 5, 2022
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clinical Trial Inc. (Tokyo, Japan; Representative Director, Hirotaka Takizawa; “3H”) announced that the companies developed and started providing “Fukusapo”, an adverse drug reaction (ADR) management supporting tool for patients as from today, aiming at the ADR management in patients receiving the […]
3
Oct 28, 2021
LOS ANGELES and TOKYO, October 27, 2021 — Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science […]
4Oct 14, 2021
System integration between ePRO (electronic patient report outcome) and electronic medical record (EMR). Possibility to confirm data input from electronic medical record itself done on the cancer patient app. Improve the quality of medical care by utilizing ICT in line with the medical field. St. Marianna University School of Medicine (Kawasaki City, Kanagawa Prefecture, President: […]
5
Sep 13, 2021
Non-small cell lung cancer (NSCLC), which is a type of epithelial lung cancer is prevalent in Japan. The absolute number of newly reported cases and deaths in men and women have increased over the years. Building awareness about the trial is an important strategy for recruitment. It is important that not just patients with NSCLC […]
6
Jul 1, 2021
South Korea has made a name in the clinical trial industry through its unprecedented growth in the industry during the past two decades. There has been several regulatory reforms, adoption of ICH-GCP and continuous investment by the government to enhance the standards and quality of clinical trial conduct to make the country a Global Centre […]
7
Nov 12, 2020
Every subject adds value to a clinical trial. Patient recruitment and retention are key aspects for the successful completion of a clinical trial. A high dropout rate can lead to a wastage of time, money and effort where any pharmaceutical company will not be able to gather prime data of primary outcomes in a clinical […]
8
May 12, 2020
Virtual Reality for the Pandemic: The clinical research space has had an overwhelming negative response in the past few months with the untimely hit by Covid-19 pandemic across the globe. With a wind down in clinical trial operations, the pharmaceutical industry has been struggling to conduct the usual onsite clinical trial visits. Thus, most pharmaceutical sponsors […]
9
Oct 20, 2017
There are various ways to approach Patient Insight research. Let’s start with the traditional method: Listening & Asking While this method is not necessarily bad, there are several risks associated with this. Patient may not be able to explain their own consumer activities Patient may rely on context (surveys and interviews have no context) Some […]
10
Sep 22, 2017
Based in the heart of Tokyo, CROèe is a PRO (Patient Recruitment Organization) that is the first of its kind in Japan. Our services include patient recruitment, feasibility studies, site selection, and much more. Check out our latest video below and we’re all about! Contact us for all of your clinical trial needs!